Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Patent Blocks Zydus After Landmark US Approval For Dapagliflozin
AstraZeneca’s Farxiga Brand Set To Stand Until October 2025
Feb 24 2022
•
By
Dean Rudge
More than a dozen ANDA sponsors are chasing the Farxiga brand • Source: Shutterstock
More from Products
More from Generics Bulletin